|
Can B Corp
CANB's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Can B 's sales fell
by -96.37 % in the third quarter of 2024 from the same quarter a year ago.
Ranking at No. 2880
Pharmacy Services & Retail Drugstore industry recorded
growth of revenues by 8.75 %
Can B net loss increased from $-2 millions, to $-3 millions in third quarter of 2024,
• More on CANB's Growth
|
|
Can B current PE on trailing twelve month basis is below Pharmacy Services & Retail Drugstore industry average.
Can B PEG ratio is at -0
Can B realized cash reduction of $ -0 per share in trailing twelve-month period. Pharmacy Services & Retail Drugstore industry recorded net loss in trailing twelve months. |
Company |
0.09 |
PE TTM
|
Industry |
49.88 |
PE TTM
|
|
Company's Price to Sales ratio is at 1.27.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.21.
• More on CANB's Valuation
|
|
|
|
|
Can B current PE on trailing twelve month basis is below Pharmacy Services & Retail Drugstore industry average.
Can B PEG ratio is at -0
Can B realized cash outflow of $ -0per share in trailing twelve-month period. Pharmacy Services & Retail Drugstore industry recorded net loss in trailing twelve months. |
Company |
0.09 |
PE TTM
|
Industry |
49.88 |
PE TTM
|
|
Company's Price to Sales ratio is at 1.27.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.21.
• More on CANB's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com